Indole-3-Carbinol, a Phytochemical Aryl Hydrocarbon Receptor-Ligand, Induces the mRNA Overexpression of UBE2L3 and Cell Proliferation Arrest.
Claudia Vanessa Arellano-GutiérrezLaura Itzel Quintas-GranadosHernán CortésManuel González Del CarmenGerardo Leyva-GómezLilia Patricia Bustamante-MontesMiguel Rodríguez-MoralesIsrael López-ReyesJuan Ramón Padilla-MendozaLorena I Rodríguez-PáezGabriela Figueroa-GonzálezOctavio Daniel Reyes-HernándezPublished in: Current issues in molecular biology (2022)
Cervical cancer (CC) is one of the most common cancers in women, and is linked to human papillomavirus (HPV) infection. The virus oncoprotein E6 binds to p53, resulting in its degradation and allowing uncontrolled cell proliferation. Meanwhile, the HPV E7 protein maintains host cell differentiation by targeting retinoblastoma tumor suppressor. The host cell can ubiquitinate E6 and E7 through UBE2L3, whose expression depends on the interaction between the aryl hydrocarbon receptor (AhR) with Xenobiotic Responsive Elements (XREs) located in the UBE2L3 gene promoter. In this study, we used cell culture to determine the effect of indole-3-carbinol (I3C) over cellular viability, apoptosis, cell proliferation, and mRNA levels of UBE2L3 and CYP1A1. In addition, patients' samples were used to determine the mRNA levels of UBE2L3 and CYP1A1 genes. We found that I3C promotes the activation of AhR and decreases cell proliferation, possibly through UBE2L3 mRNA induction, which would result in the ubiquitination of HPV E7. Since there is a strong requirement for selective and cost-effective cancer treatments, natural AhR ligands such as I3C could represent a novel strategy for cancer treatment.
Keyphrases
- cell proliferation
- binding protein
- cell cycle
- high grade
- pi k akt
- end stage renal disease
- cervical cancer screening
- ejection fraction
- oxidative stress
- dna methylation
- newly diagnosed
- poor prognosis
- gene expression
- chronic kidney disease
- endoplasmic reticulum stress
- polycystic ovary syndrome
- prognostic factors
- type diabetes
- cancer therapy
- squamous cell carcinoma
- peritoneal dialysis
- genome wide identification
- small molecule
- young adults
- childhood cancer
- patient reported outcomes
- squamous cell